We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+11.29%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.06B
AUM Growth
+$40.2M
Cap. Flow
-$31.9M
Cap. Flow %
-3%
Top 10 Hldgs %
38.82%
Holding
432
New
78
Increased
76
Reduced
169
Closed
68

Top Sells

Rank Stock Value
1
DEN
Denbury Inc.
DEN
+$25.7M
2
EXE
Expand Energy Corp
EXE
+$17.9M
3
AR icon
Antero Resources
AR
+$13.6M
4
ACN icon
Accenture
ACN
+$10.7M
5
HD icon
Home Depot
HD
+$8.5M

Sector Composition

Rank Sector Weight
1 Energy 37.03%
2 Healthcare 10.56%
3 Technology 9.98%
4 Financials 9.12%
5 Consumer Discretionary 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAC icon
176
Danaos Corp
DAC
$2.55B
$872K 0.08%
16,564
-139
-0.8% -$7.83K
STRL icon
177
Sterling Infrastructure
STRL
$20.3B
$872K 0.08%
26,589
+9,553
+56% +$281K
CASS icon
178
Cass Information Systems
CASS
$698M
$847K 0.08%
+18,475
New +$774K
FNF icon
179
Fidelity National Financial
FNF
$13.9B
$844K 0.08%
22,439
-1,145
-5% -$43K
EXLS icon
180
EXL Service
EXLS
$4.23B
$843K 0.08%
24,865
+10
+0% +$347
IRM icon
181
Iron Mountain
IRM
$38.2B
$843K 0.08%
16,901
FDUS icon
182
Fidus Investment
FDUS
$737M
$835K 0.08%
43,863
-2,016
-4% -$38.3K
LSCC icon
183
Lattice Semiconductor
LSCC
$17.6B
$834K 0.08%
+12,855
New +$776K
TCPC icon
184
BlackRock TCP Capital
TCPC
$265M
$822K 0.08%
63,554
+5,861
+10% +$73.1K
KRYS icon
185
Krystal Biotech
KRYS
$9.88B
$820K 0.08%
10,354
-465
-4% -$34.5K
KDNY
186
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$815K 0.08%
31,101
+2,207
+8% +$48.9K
IBTX
187
DELISTED
Independent Bank Group, Inc.
IBTX
$811K 0.08%
13,492
+5,154
+62% +$328K
EXAS
188
DELISTED
Exact Sciences
EXAS
$782K 0.07%
+15,800
New +$646K
SAR icon
189
Saratoga Investment
SAR
$309M
$774K 0.07%
30,351
-5,370
-15% -$128K
MGPI icon
190
MGP Ingredients
MGPI
$378M
$770K 0.07%
+7,234
New +$808K
RYZ
191
Ryerson Holding Corp
RYZ
$1.6B
$755K 0.07%
+24,943
New +$740K
XLE icon
192
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$743K 0.07%
16,986
+292
+2% +$12.7K
FIGS icon
193
FIGS
FIGS
$1.59B
$740K 0.07%
+109,899
New +$790K
RWAY icon
194
Runway Growth Finance
RWAY
$228M
$737K 0.07%
63,616
+5,858
+10% +$70.5K
CUE icon
195
Cue Biopharma
CUE
$135M
$733K 0.07%
8,574
OLK
196
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$732K 0.07%
+28,860
New +$581K
BBW icon
197
Build-A-Bear
BBW
$423M
$730K 0.07%
+30,602
New +$590K
ALT icon
198
Altimmune
ALT
$539M
$727K 0.07%
44,216
+9,066
+26% +$102K
NETC
199
DELISTED
Nabors Energy Transition Corp.
NETC
$721K 0.07%
70,190
-10,130
-13% -$103K
UFPI icon
200
UFP Industries
UFPI
$4.97B
$720K 0.07%
9,088
+11
+0.1% +$840

Similar funds

Advisory Research's Q4 2022 Portfolio in Review

As of Q4 2022, Advisory Research held 432 positions worth $1.06B, up 3.9% from $1.02B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Advisory Research withdrew a net $31.9M in Q4 2022, closing 68 positions and reducing 169 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $6.06M position sold in full.

By sector, the portfolio is most concentrated in Energy at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Advisory Research opened a new position in iShares Russell 2000 ETF worth $5.37M.

  • Advisory Research's largest Q4 2022 buy was iShares Russell 2000 ETF: 30,811 shares worth $5.37M.
  • Advisory Research added most to Diamondback Energy in Q4 2022, an estimated $61.4M increase.
  • Advisory Research's biggest Q4 2022 reduction was Denbury Inc., cutting an estimated $25.7M.
  • Advisory Research fully exited IAA, Inc. Common Stock in Q4 2022, selling an estimated $6.06M.
  • Advisory Research's ten largest holdings make up 39% of its $1.06B portfolio in Q4 2022.
  • Advisory Research opened 78 new positions and closed 68 in Q4 2022.
  • Advisory Research's portfolio value rose 3.9% quarter-over-quarter to $1.06B.

Based on Advisory Research's 13F filing for Q4 2022, filed 13 Feb 2023.